Tag: #Global Trends

Biopharmaceutical giant Eli Lilly is finalizing clinical preparations to launch a Phase 2 study for an investigational lipid-lowering gene-editing asset... Read more

South Korean drugmaker Hanmi Pharmaceutical has finalized a definitive supply agreement with global healthcare enterprise Organon to export three finished... Read more

One of the few publicly traded pharmaceutical heavyweights in Italy may soon transition to private ownership, following a definitive $12.4... Read more

Biopharmaceutical multinational Bristol Myers Squibb (BMS), historically recognized for its market leadership in oncology and cell therapies, is actively diversifying... Read more

Biopharmaceutical multinational Gilead Sciences has announced that its investigational formulation targeting a rare and severe liver infection has officially secured... Read more

A combined therapeutic regimen engineered by Moderna and Merck & Co. has demonstrated significant long-term clinical efficacy, reducing the risk... Read more

The U.S. Food and Drug Administration (FDA) has announced plans to convene a panel of independent external experts next month... Read more

A competitive pricing strategy implemented for oral obesity medications developed by Novo Nordisk and Eli Lilly is altering the U.S.... Read more

Biopharmaceutical multinational Gilead Sciences and the World Health Organization (WHO) have formalized an expanded global health covenant aimed at eliminating... Read more